Standard Practice for Evaluation of Preoperative, Precatheterization, or Preinjection Skin Preparations

SIGNIFICANCE AND USE
5.1 These procedures should be used to test topical antimicrobial-containing preparations that are intended to be fast-acting in reducing significantly the number of microorganisms on intact skin immediately and, for preoperative and vascular precatheterization preparations, maintenance of some degree of reduction for an extended time.
SCOPE
1.1 The practice is designed to measure the reduction of the microflora of the skin.  
1.2 A knowledge of microbiological techniques is required for these procedures.  
1.3 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.  
1.3.1 Exception—In this practice, metric units are used for all applications except for linear measure, in which case inches are used, and metric units follow in parentheses.  
1.4 Performance of this procedure requires a knowledge of regulations pertaining to the protection of human subjects (1).2
Note 1: Importantly, it must be noted that the FDA currently does not accept data resulting from procedures in this Method for testing products for approval as Vascular Precatheterization Skin Preparations.  
1.5 This standard does not purport to address all of the safety problems, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.  
1.6 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.

General Information

Status
Published
Publication Date
31-Mar-2023
Current Stage
Ref Project

Buy Standard

Standard
ASTM E1173-23 - Standard Practice for Evaluation of Preoperative, Precatheterization, or Preinjection Skin Preparations
English language
6 pages
sale 15% off
Preview
sale 15% off
Preview
Standard
REDLINE ASTM E1173-23 - Standard Practice for Evaluation of Preoperative, Precatheterization, or Preinjection Skin Preparations
English language
6 pages
sale 15% off
Preview
sale 15% off
Preview

Standards Content (Sample)

This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the
Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
Designation: E1173 − 23
Standard Practice for
Evaluation of Preoperative, Precatheterization, or
1
Preinjection Skin Preparations
This standard is issued under the fixed designation E1173; the number immediately following the designation indicates the year of
original adoption or, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval. A
superscript epsilon (´) indicates an editorial change since the last revision or reapproval.
1. Scope E1054 Practices for Evaluation of Inactivators of Antimicro-
bial Agents
1.1 The practice is designed to measure the reduction of the
E1874 Practice for Recovery of Microorganisms From Skin
microflora of the skin.
using the Cup Scrub Technique
1.2 A knowledge of microbiological techniques is required
E2756 Terminology Relating to Antimicrobial and Antiviral
for these procedures.
Agents
1.3 The values stated in SI units are to be regarded as
3. Terminology
standard. No other units of measurement are included in this
standard.
3.1 Terms used in this standard are defined in E2756,
1.3.1 Exception—In this practice, metric units are used for Standard Terminology Relating to Antimicrobial and Antiviral
all applications except for linear measure, in which case inches
Agents. Others defined below are specific to their use in this
are used, and metric units follow in parentheses. document.
1.4 Performance of this procedure requires a knowledge of
3.2 Definitions of Terms Specific to This Standard:
2
regulations pertaining to the protection of human subjects (1). 3.2.1 active ingredient, n—a substance added to a formula-
NOTE 1—Importantly, it must be noted that the FDA currently does not
tion specifically for the inhibition or inactivation of microor-
accept data resulting from procedures in this Method for testing products
ganisms.
for approval as Vascular Precatheterization Skin Preparations.
3.2.2 inguen, n—groin: the junctional region between the
1.5 This standard does not purport to address all of the
abdomen and thigh; pl. inguina.
safety problems, if any, associated with its use. It is the
3.2.3 inguinal crease, n—the discrete region of flexure
responsibility of the user of this standard to establish appro-
between the abdomen and the thigh.
priate safety, health, and environmental practices and deter-
mine the applicability of regulatory limitations prior to use.
3.2.4 sampling fluid, n—a recovery fluid that contains a
1.6 This international standard was developed in accor-
neutralizer demonstrated to inactivate or quench the active
dance with internationally recognized principles on standard-
ingredient(s) in the test formulation and the positive and
ization established in the Decision on Principles for the
negative control formulations. See Practices E1054.
Development of International Standards, Guides and Recom-
3.2.5 test formulation, n—a formulation containing an ac-
mendations issued by the World Trade Organization Technical
tive ingredient(s).
Barriers to Trade (TBT) Committee.
4. Summary of Test Method
2. Referenced Documents
4.1 This practice is conducted on human subjects selected
3
2.1 ASTM Standards:
randomly from a group of volunteers who, after refraining
voluntarily from using topical and oral antimicrobials for at
least two weeks (14 days), exhibit acceptably high normal flora
1
This practice is under the jurisdiction of ASTM Committee E35 on Pesticides,
counts on the skin sites to be used in testing (see Section 8).
Antimicrobials, and Alternative Control Agents and is the direct responsibility of
Subcommittee E35.15 on Antimicrobial Agents.
4.2 The antimicrobial activity of preoperative, vascular
Current edition approved April 1, 2023. Published May 2023. Originally
precatheterization, or preinjection skin preparations and of
approved in 1987. Last previous edition approved in 2015 as E1173 – 15. DOI:
controls is measured by comparing microbial counts, obtained
10.1520/E1173-23.
2
at various time intervals after application of a formulation to
The boldface numbers in parentheses refer to the list of references at the end of
this standard.
skin sites to counts obtained from those same sites prior to
3
For referenced ASTM standards, visit the ASTM website, www.astm.org, or
application of a formulation. Skin sites recommended for use
contact ASTM Customer Service at service@astm.org. For Annual Book of ASTM
in testing are: (1) the inguinal region and the abdomen for
Standards volume information, refer to the standard’s Document Summary page on
the ASTM website. preoperative skin preparations; (2) the inguinal region, the
Copyright © ASTM International, 100 Barr Harbor Drive, PO Box C700, West Consho
...

This document is not an ASTM standard and is intended only to provide the user of an ASTM standard an indication of what changes have been made to the previous version. Because
it may not be technically possible to adequately depict all changes accurately, ASTM recommends that users consult prior editions as appropriate. In all cases only the current version
of the standard as published by ASTM is to be considered the official document.
Designation: E1173 − 15 E1173 − 23
Standard Test Method Practice for
Evaluation of Preoperative, Precatheterization, or
1
Preinjection Skin Preparations
This standard is issued under the fixed designation E1173; the number immediately following the designation indicates the year of
original adoption or, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval. A
superscript epsilon (´) indicates an editorial change since the last revision or reapproval.
1. Scope
1.1 The test method practice is designed to measure the reduction of the microflora of the skin.
1.2 A knowledge of microbiological techniques is required for these procedures.
1.3 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.
1.3.1 Exception—In this test method, practice, metric units are used for all applications except for linear measure, in which case
inches are used, and metric units follow in parentheses.
2
1.4 Performance of this procedure requires a knowledge of regulations pertaining to the protection of human subjects (1).
NOTE 1—Importantly, it must be noted that the FDA currently does not accept data resulting from procedures in this Method for testing products for
approval as Vascular Precatheterization Skin Preparations.
1.5 This standard does not purport to address all of the safety problems, if any, associated with its use. It is the responsibility
of the user of this standard to establish appropriate safety and healthsafety, health, and environmental practices and determine
the applicability of regulatory limitations prior to use.
1.6 This international standard was developed in accordance with internationally recognized principles on standardization
established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued
by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
2. Referenced Documents
3
2.1 ASTM Standards:
E1054 Practices for Evaluation of Inactivators of Antimicrobial Agents
E1874 Practice for Recovery of Microorganisms From Skin using the Cup Scrub Technique
E2756 Terminology Relating to Antimicrobial and Antiviral Agents
1
This test method practice is under the jurisdiction of ASTM Committee E35 on Pesticides, Antimicrobials, and Alternative Control Agents and is the direct responsibility
of Subcommittee E35.15 on Antimicrobial Agents.
Current edition approved May 1, 2015April 1, 2023. Published July 2015May 2023. Originally approved in 1987. Last previous edition approved in 20092015 as
E1173 – 01E1173 – 15.(2009). DOI: 10.1520/E1173-15.10.1520/E1173-23.
2
The boldface numbers in parentheses refer to the list of references at the end of this standard.
3
For referenced ASTM standards, visit the ASTM website, www.astm.org, or contact ASTM Customer Service at service@astm.org. For Annual Book of ASTM Standards
volume information, refer to the standard’s Document Summary page on the ASTM website.
Copyright © ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959. United States
1

---------------------- Page: 1 ----------------------
E1173 − 23
3. Terminology
3.1 Terms used in this standard are defined in E2756, Standard Terminology Relating to Antimicrobial and Antiviral Agents.
Others defined below are specific to their use in this document.
3.2 Definitions of Terms Specific to This Standard:
3.2.1 active ingredient, n—a substance added to a formulation specifically for the inhibition or inactivation of microorganisms.
3.2.2 inguen, n—groin: the junctional region between the abdomen and thigh; pl. inguina.
3.2.3 inguinal crease—crease, n—the discrete region of flexure between the abdomen and the thigh.
3.2.4 sampling fluid—fluid, n—a recovery fluid that contains a neutralizer demonstrated to inactivate or quench the active
ingredient(s) in the test and reference formulation and the positive and negative control formulations. See Test Method Practices
E1054.
3.2.5 test formulation—formulation, n—a formulation containing an active ingredient(s).
4. Summary of Test Method
4.1 These test methods are This practice is conducted on human subjects selected randomly from a group of volunteers who, after
refraining voluntarily from using topical and oral antimicrobials for at least two weeks (14 days), exhibit acceptably high normal
flora counts on the skin sites to be used in testing (see Section 8).
4.2 The antimicrobial activity of preoperative, vascular precathet
...

Questions, Comments and Discussion

Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.